Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cerebellar Modulation of Cognition in Psychosis — Stella

Home/Schizophrenia/Cerebellar Modulation of Cognition in Psychosis

View on ClinicalTrials.gov

Recruiting

Back to Schizophrenia trials

Cerebellar Modulation of Cognition in Psychosis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

McLean Hospital, Belmont, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Key details

Sponsor

Mclean Hospital

Collaborators

Beth Israel Deaconess Medical Center

Enrollment target

~95 participants

Started

July 2024

Primary completion

December 2029

Age range

18 Years – 55 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.